| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 752329 | (Z)-6-(2-(pyridin-2-ylmethylene)hydrazinyl)-9H-purine | 0.0186200143729975 | 0.078198081 |
| NSC 753393 | 3-[2-(5-fluoro-1-methyl-1H-indol-3-yl)-1,3-thiazol-4-yl]-1-methyl-1H-pyrrolo[2,3-b]pyridine | 0.0186200143729975 | -0.043002088 |
| NSC 756133 | GSK1007102B | 0.0186200143729975 | -0.24441766 |
| NSC 756193 | GSK978744A | 0.0186200143729975 | -0.35024738 |
| NSC 760958 | Null | 0.0186200143729975 | -0.29507763 |
| NSC 107043 | Null | 0.0219024304994663 | -0.11531762 |
| NSC 114340 | Ophiobolin A | 0.0219024304994663 | 0.007178851 |
| NSC 132791 | Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo | 0.0219024304994663 | 0.10992606 |
| NSC 135073 | WITHACNISTIN | 0.0219024304994663 | -0.04793504 |
| NSC 168516 | Benzene, 1,1'-(1,2-ethanediyl)bis[2,5-dimethoxy- | 0.0219024304994663 | -0.20467546 |